Literature DB >> 6325434

Direct photoaffinity labeling of the high affinity nitrendipine-binding site in subcellular membrane fractions isolated from canine myocardium.

K P Campbell, G M Lipshutz, G H Denney.   

Abstract

[3H]Nitrendipine and high intensity ultraviolet irradiation have been used to photoaffinity label the protein component of the high affinity nitrendipine-binding site in subcellular membrane fractions from canine cardiac muscle. Irradiation of isolated cardiac membranes in the presence of [3H]nitrendipine resulted in the covalent labeling of a protein component that migrated on sodium dodecyl sulfate-polyacrylamide gels with an apparent molecular weight of 32,000. Incorporation of [3H]nitrendipine did not occur in the absence of irradiation. The photoaffinity labeling of the 32,000-Da protein by [3H]nitrendipine was inhibited by excess unlabeled nitrendipine, nifedipine, or verapamil. EDTA, ATP, and La3+, which are known to reduce high affinity nitrendipine binding, also inhibited the photoaffinity labeling of this membrane protein by [3H]nitrendipine. The 32,000-Da [3H]nitrendipine-labeled protein was found to be enriched in the ryanodine-sensitive fraction of cardiac sarcoplasmic reticulum and absent from the ryanodine-insensitive fraction of cardiac sarcoplasmic reticulum which is known to lack high affinity nitrendipine binding. Therefore, the 32,000-Da photoaffinity-labeled [3H]nitrendipine-binding protein exhibits properties identical to those expected for the protein component of the high affinity nitrendipine-binding site in isolated cardiac membranes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325434

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  The purification of ion channels from excitable cells.

Authors:  J A Talvenheimo
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

2.  Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.

Authors:  H Affolter; R Coronado
Journal:  Biophys J       Date:  1985-08       Impact factor: 4.033

3.  Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.

Authors:  D R Ferry; A Goll; H Glossmann
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

4.  Subcellular distribution and isolation of the Ca2+ antagonist receptor associated with the voltage regulated Ca2+ channel from rabbit heart muscle.

Authors:  B S Tuana; B J Murphy; Q Yi
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

Review 5.  Biochemical properties of isolated transverse tubular membranes.

Authors:  R A Sabbadini; A S Dahms
Journal:  J Bioenerg Biomembr       Date:  1989-04       Impact factor: 2.945

6.  Monoclonal antibody specific for the transverse tubular membrane of skeletal muscle activates the dihydropyridine-sensitive Ca2+ channel.

Authors:  N N Malouf; R Coronado; D McMahon; G Meissner; G Y Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Purification and affinity labeling of dihydropyridine receptor from rabbit skeletal muscle membranes.

Authors:  U Kanngiesser; P Nalik; O Pongs
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.

Authors:  K P Campbell; A Sharp; M Strom; S D Kahl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney.

Authors:  G Zernig; H Glossmann
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

Review 10.  Redox regulation, NF-kappaB, and atrial fibrillation.

Authors:  Ge Gao; Samuel C Dudley
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.